Chesnara Plc: Fourth acquisition in two years
12 November 2026
Stryker Corporation (NYSE: SYK) stands as a formidable player in the healthcare sector, prominently known for its innovation in medical devices. With a robust market capitalization..
Sanofi (NYSE: SNY), a titan in the healthcare sector, continues to capture investor attention with its promising outlook and substantial dividend yield. Headquartered in Paris, France,..
Investors eyeing the healthcare sector might find Intuitive Surgical, Inc. (NASDAQ: ISRG) an intriguing proposition, given its substantial $199.67 billion market cap and impressive 19.2% revenue..
Elevance Health, Inc. (NYSE: ELV), a titan in the healthcare plans sector, is drawing attention from investors with a substantial market capitalization of $88.87 billion. This..
Danaher Corporation (NYSE: DHR), a titan in the healthcare sector, has consistently commanded investor attention with its robust portfolio spanning biotechnology, life sciences, and diagnostics. With..
AstraZeneca PLC (NASDAQ: AZN), a titan in the healthcare sector, continues to capture investor attention with its robust portfolio of prescription medicines and strategic innovations. With..
MBX Biosciences, Inc. (NASDAQ: MBX) is capturing significant attention in the biotechnology sector, particularly among investors seeking high-growth opportunities in the healthcare industry. The company, based..
PureTech Health plc (NASDAQ: PRTC), a burgeoning entity in the biotechnology sector, is capturing the attention of investors with its remarkable potential upside of 183.24%. With..
For investors with a keen eye on the healthcare sector, Prothena Corporation plc (PRTA) offers a compelling opportunity within the biotechnology industry. Based in Dublin, Ireland,..
Tourmaline Bio, Inc. (NASDAQ: TRML), a biotechnology firm at the forefront of developing treatments for immune and inflammatory diseases, has captured investor attention with a remarkable..
COMPASS Pathways Plc (NASDAQ: CMPS) is catching the attention of investors, with a remarkable potential upside of 271.26% based on the average analyst target price of..
Treace Medical Concepts, Inc. (NASDAQ: TMCI), a U.S.-based leader in the medical devices sector, presents an intriguing opportunity for investors with its potential 68.61% upside. Specializing..
AngioDynamics, Inc. (NASDAQ: ANGO), a prominent player in the healthcare sector, specializes in the design and manufacture of innovative medical devices aimed at treating peripheral vascular..
Altimmune, Inc. (NASDAQ: ALT), a clinical-stage biopharmaceutical company, is attracting significant attention from investors, particularly due to its bold foray into the treatment of obesity and..
Autolus Therapeutics plc (NASDAQ: AUTL), a clinical-stage biopharmaceutical company based in the United Kingdom, is capturing the attention of investors with its transformative approach to cancer..
Maze Therapeutics, Inc. (MAZE), a burgeoning entity within the biotechnology sector, is capturing attention with its compelling growth potential and strategic focus on precision medicines. With..
Abivax SA (ABVX), a prominent player in the biotechnology sector, is grabbing the spotlight with a potential upside of 355.74%, according to analysts’ target price projections...
Regulus Therapeutics Inc. (RGLS), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its innovative approach to drug discovery. Specializing in targeting microRNAs..
Sage Therapeutics, Inc. (NASDAQ: SAGE), a biotech firm specializing in brain health medicines, has recently captured investor attention due to its intriguing potential upside. The company,..
